Aurora Cannabis (ACB) Non Operating Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Non Operating Income of -$34272.7 for Q1 2026, up 99.67% year-over-year from -$17164.4 in Q1 2025, and up 93.2% quarter-over-quarter from -$504111.7 in Q4 2025.
Aurora Cannabis (ACB) Non Operating Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Non Operating Income for 10 consecutive years, with -$34272.7 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 99.67% year-over-year to -$34272.7; the TTM figure through Mar 2026 stood at -$3.4 million (up 59.81% YoY), while the FY2026 annual figure was $525028.1, up 103.4% from the prior year.
- Non Operating Income climbed to -$34272.7 in Q1 2026 per ACB's latest filing, from -$504111.7 in the prior quarter.
- Across five years, Non Operating Income topped out at $742.1 million in Q1 2022 and bottomed at -$11.7 million in Q2 2022.
- Historically, Non Operating Income has averaged $48.9 million across 5 years, with a median of -$1.3 million in 2025.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 5628.28% — and 2025, when it slumped 156.04%.
- Aurora Cannabis' Non Operating Income stood at $5.7 million in 2022, then sank by 103.48% to -$199000.0 in 2023, then soared by 2522.61% to $4.8 million in 2024, then plunged by 110.46% to -$504111.7 in 2025, then soared by 93.2% to -$34272.7 in 2026.
- Business Quant data shows ACB's Non Operating Income at -$34272.7 in Q1 2026, -$504111.7 in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Aurora Cannabis | 233.45 Mn | 161.14 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,272.67 |
| Dec 31, 2025 | -504,111.66 |
| Sep 30, 2025 | -1.61 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | -10.49 Mn |
| Dec 31, 2024 | 4.82 Mn |
| Sep 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | 18.72 Mn |
| Dec 31, 2023 | -199,000.00 |
| Sep 30, 2023 | -3.06 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Sep 30, 2022 | -6.28 Mn |
| Jun 30, 2022 | -11.71 Mn |
| Mar 31, 2022 | 742.10 Mn |
| Dec 31, 2021 | -12.62 Mn |
| Sep 30, 2021 | 34.28 Mn |
| Jun 30, 2021 | -298.10 Mn |
| Mar 31, 2021 | -13.42 Mn |
| Dec 31, 2020 | -14.48 Mn |